30-day mortality risk in ST-elevation MI
Total Score
Low 30-day mortality risk (~1-4%).
Disclaimer: The clinical scoring and algorithms on this platform are intended strictly for professional informational purposes. They do not constitute a definitive medical diagnosis, treatment, or clinical decision. The final judgment and responsibility lie with the treating physician.
Yasal Uyarı: Bu platformdaki klinik skorlamalar ve algoritmalar yalnızca sağlık profesyonellerini bilgilendirme amaçlıdır. Herhangi bir kesin tıbbi teşhis, tedavi veya klinik karar yerine geçemez. Nihai karar ve sorumluluk hastayı yatak başında değerlendiren hekime aittir.
The TIMI Risk Score for STEMI is a well-validated bedside tool developed to estimate the 30-day mortality risk in patients presenting with ST-Elevation Myocardial Infarction. It relies heavily on patient demographics, vital signs on presentation, and the specific electrocardiographic localization of the infarction.
Anterior myocardial infarctions or the presence of a new Left Bundle Branch Block (LBBB) carry significantly higher mortality due to the extensive mass of myocardium at risk (usually LAD occlusion) and are heavily weighted in this scoring system.
Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-2037.
Disclaimer: The clinical scoring and algorithms on this platform are intended strictly for professional informational purposes. They do not constitute a definitive medical diagnosis, treatment, or clinical decision. The final judgment and responsibility lie with the treating physician.